WinstonWınston
Back
ENvue Medical logo

ENvue Medical

FEED
14
Medical - Specialties · Healthcare
Exchange
NASDAQ Global Market
Winston Score
14
Winston is worried
Weak fundamentals across most pillars.
Data as of Aug 23, 2026 · filings through Mar 31, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Winston Score History

The full picture

ENvue Medical is a small medical device company focused on developing imaging and guidance technology used during medical procedures. Its products are designed to help doctors see more clearly inside the body in real time, improving accuracy during minimally invasive treatments. The company targets hospitals and interventional specialists as its primary customers.

ENvue Medical generates revenue through medical device sales and related services, though the company is currently in an early commercial stage. Its deeply negative operating margin and negative gross margin signal that it is spending far more than it earns, which is common for pre-revenue or early-revenue medical device companies. The main risk is that the company must raise additional capital to fund operations while simultaneously proving its technology works well enough to win adoption from hospitals and physicians in a competitive medical imaging market.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-36.3% YoY

YoY Growth Rate

Revenue declining

EPS Growth

<−1,000% YoY

YoY Growth Rate

Earnings declining

Insider Activity

0.8%ownership

Relatively low insider ownership

Cash Runway

~2 months

$2M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

ENvue Medical has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
-8.4%
Thin — -8.4% gross margin
Profit after running costs
Operating Margin
-568.3%
Losing money on operations — -568.3%
Return on the money invested
ROCE
-41.0%
Weak — -41.0% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-18.1%
Shrinking sales (-18.1% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-569.1%
Burning cash (-569.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.04
Conservative — low debt load (0.04)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial